470 related articles for article (PubMed ID: 18178025)
1. [Chemotherapy-induced febrile neutropenia: about 200 episodes. Clinical, microbiological and therapeutic characteristics].
Gharbi O; Ben Hadj Hassen S; Kaabia N; Limam S; Hadj Amor M; Ben Fatma L; Landolsi A; Hochlef M; Letaief A; Boukadida J; Ben Ahmed S
Pathol Biol (Paris); 2008 May; 56(3):154-7. PubMed ID: 18178025
[TBL] [Abstract][Full Text] [Related]
2. [Chemotherapy-induced febrile neutropenia: About 186 episodes. Clinical, microbiological and therapeutic characteristics].
Masmoudi S; Khanfir A; Maalej-Mezghan S; Hammami A; Frikha M
Tunis Med; 2015 Apr; 93(4):217-22. PubMed ID: 26375737
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic factors for febrile neutropenia].
Ray-Coquard I; Borg C; Bachelot T; Fayette J; Zufferey L; Guastalla JP; Ghesquière H; Blay JY; Sebban C; Marec-Bérard P; Biron P
Bull Cancer; 2006 May; 93(5):501-6. PubMed ID: 16777629
[TBL] [Abstract][Full Text] [Related]
4. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.
Ozkaynak MF; Krailo M; Chen Z; Feusner J
Pediatr Blood Cancer; 2005 Sep; 45(3):274-80. PubMed ID: 15806544
[TBL] [Abstract][Full Text] [Related]
5. Episodes of fever and neutropenia in children with cancer in a tertiary care medical center in Turkey.
Tezcan G; Kupesiz A; Ozturk F; Ogunc D; Gultekin M; Yesilipek A; Hazar V
Pediatr Hematol Oncol; 2006; 23(3):217-29. PubMed ID: 16517538
[TBL] [Abstract][Full Text] [Related]
6. Retrospective review of gynecologic oncology patients with therapy-induced neutropenic fever.
McMeekin DS; Gazzaniga C; Berman M; DiSaia P; Manetta A
Gynecol Oncol; 1996 Aug; 62(2):247-53. PubMed ID: 8751557
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management.
Crawford J; Dale DC; Lyman GH
Cancer; 2004 Jan; 100(2):228-37. PubMed ID: 14716755
[TBL] [Abstract][Full Text] [Related]
8. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
Ghalaut PS; Sen R; Dixit G
J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients.
Oude Nijhuis C; Kamps WA; Daenen SM; Gietema JA; van der Graaf WT; Groen HJ; Vellenga E; Ten Vergert EM; Vermeulen KM; de Vries-Hospers HG; de Bont ES
J Clin Oncol; 2005 Oct; 23(30):7437-44. PubMed ID: 16234511
[TBL] [Abstract][Full Text] [Related]
10. Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors.
Kebudi R; Görgün O; Ayan I; Gürler N; Akici F; Töreci K
Med Pediatr Oncol; 2001 Apr; 36(4):434-41. PubMed ID: 11260566
[TBL] [Abstract][Full Text] [Related]
11. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
Mullen CA; Petropoulos D; Roberts WM; Rytting M; Zipf T; Chan KW; Culbert SJ; Danielson M; Jeha SS; Kuttesch JF; Rolston KV
Cancer; 1999 Jul; 86(1):126-34. PubMed ID: 10391572
[TBL] [Abstract][Full Text] [Related]
12. Immediate vs. delayed imipenem treatment in cancer patients with profound neutropenia induced by high-dose chemotherapy: results of a randomized study.
García-Sáenz JA; Martín M; Casado A; Pérez-Segura P; Manrique I; Flores L; Macias JA; Cámara JC; Perezagua C; Díaz-Rubio E
Rev Esp Quimioter; 2002 Sep; 15(3):257-63. PubMed ID: 12582429
[TBL] [Abstract][Full Text] [Related]
13. [High risk febrile neutropenia in acute leukemia. The experience of a public hospital. National Program of Antineoplastic Drugs in Adult, Hospital del Salvador, 1991-2001].
Puga B; Puga I; Cabrera ME; Undurraga MS; Guerra C; Urrejola G; Toro P
Rev Med Chil; 2003 Sep; 131(9):1023-30. PubMed ID: 14635589
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of empiric monotherapy with ceftazidime for low-risk grade IV febrile neutropenia after cytotoxic chemotherapy in cancer patients.
Chernobelski P; Lavrenkov K; Rimar D; Riesenberg K; Schlaeffer F; Ariad S; Mermershtain W
Chemotherapy; 2006; 52(4):185-9. PubMed ID: 16675902
[TBL] [Abstract][Full Text] [Related]
15. Cefepime plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
Hamidah A; Lim YS; Zulkifli SZ; Zarina AL; Nordiah AJ; Jamal R
Singapore Med J; 2007 Jul; 48(7):615-9. PubMed ID: 17609821
[TBL] [Abstract][Full Text] [Related]
16. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.
Bucaneve G; Micozzi A; Menichetti F; Martino P; Dionisi MS; Martinelli G; Allione B; D'Antonio D; Buelli M; Nosari AM; Cilloni D; Zuffa E; Cantaffa R; Specchia G; Amadori S; Fabbiano F; Deliliers GL; Lauria F; Foà R; Del Favero A;
N Engl J Med; 2005 Sep; 353(10):977-87. PubMed ID: 16148283
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and therapeutic outcome of patients with febrile neutropenia who present in shock: need for better strategies.
Malik I; Hussain M; Yousuf H
J Infect; 2001 Feb; 42(2):120-5. PubMed ID: 11531318
[TBL] [Abstract][Full Text] [Related]
18. Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors.
Oguz A; Karadeniz C; Citak EC; Cil V; Eldes N
Pediatr Hematol Oncol; 2006; 23(3):245-53. PubMed ID: 16517540
[TBL] [Abstract][Full Text] [Related]
19. Febrile neutropenia in paediatric peripheral blood stem cell transplantation, in -vitro sensitivity data and clinical response to empirical antibiotic therapy.
Ansari SH; Nasim S; Ahmed A; Irfan M; Ishaque A; Farzana T; Panjwani VK; Taj M; Shamsi TS
J Coll Physicians Surg Pak; 2006 Nov; 16(11):704-8. PubMed ID: 17052420
[TBL] [Abstract][Full Text] [Related]
20. Prospective audit of treatment of paediatric febrile neutropenia in Australasia.
Chamberlain JD; Smibert E; Skeen J; Alvaro F
J Paediatr Child Health; 2005 Nov; 41(11):598-603. PubMed ID: 16398846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
